Skip to main content
FinSpry Logo
FinSpry
LFCR logo
LFCR
(NASDAQ)
Lifecore Biomedical, Inc.
$4.57-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Lifecore Biomedical (LFCR) Stock Price & Financial Analysis

Lifecore Biomedical Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.22 - $4.52
52-Week High$8.98
52-Week Low$3.63
Open$4.32
Volume161.07K
Average Volume (3M)257.42K
Market Cap164.87M
Shares Outstanding37.47M
Price to Sales (P/S)1.20
Price to Book (P/B)-11.61
EV/EBITDA-74.32
Revenue (TTM)137.74M
Net Income (TTM)-37.94M
Free Cash Flow (TTM)3.68M
EPS (TTM)$-1.01
Profit Margin-27.55%
Operating Margin-4.99%
50-Day MA$5.02
200-Day MA$6.89
52-Week Change-35.53%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Lifecore Biomedical

What is the current stock price for LFCR?

As of the latest trading session, LFCR stock trades at $4.38. The 52-week range is $3.63–$8.98, with a day range of $4.22–$4.52.

What is the P/E ratio for LFCR?

The P/E ratio (Price-to-Earnings) for LFCR is shown in the Key Statistics section. This valuation metric helps compare Lifecore Biomedical, Inc. to industry peers.

Does LFCR pay dividends?

Lifecore Biomedical does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for LFCR?

Based on 1 analyst, the consensus for LFCR is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of LFCR?

Lifecore Biomedical's market capitalization is $164.1M, classifying it as a micro-cap company. Lifecore Biomedical operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.